Chemomab Therapeutics Ltd (CMMB)

NASDAQ

$1.50

Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company is headquartered in Tel Aviv, Israel.

Website: https://www.chemomab.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Strong Buy

Target: $5 (+233.33%)

Market Cap

$11M

Beta (5Y)

0.98

Price Chart

Adjust inflation

Log

Valuation

Market Cap$11M

Forward P/E12.94

P/B1.04

Profitability

EBITDA-$32M

EPS-$10.84

Growth & Risk

Beta (5Y)0.98

Sharpe Ratio-0.87